A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

Austin Health /ID# 171189, Heidelberg

Peninsula Oncology Centre /ID# 164372, Frankston

Virginia Cancer Specialists - Fairfax /ID# 155266, Fairfax

Hospital Universitario Fundacion Jimenez Diaz /ID# 200128, Madrid

Hospital Universitario HM Sanchinarro /ID# 200127, Madrid

Carolina BioOncology Institute /ID# 155265, Huntersville

Hospital Universitario Puerta de Hierro - Majadahonda /ID# 200129, Majadahonda

Institut Bergonie /ID# 162665, Bordeaux

Duplicate_Institut Regional du Cancer /ID# 163609, Montpellier

Hospital Universitario y Politecnico La Fe /ID# 200975, Valencia

Centre Leon Berard /ID# 162663, Lyon

University of Texas MD Anderson Cancer Center /ID# 155263, Houston

The Angeles Clinic and Researc /ID# 156324, Los Angeles

Institut Gustave Roussy /ID# 162666, Villejuif

The University of Chicago Medical Center /ID# 155264, Chicago

Massachusetts General Hospital /ID# 155267, Boston

Tennessee Oncology-Nashville Centennial /ID# 158654, Nashville

University Health Network_Princess Margaret Cancer Centre /ID# 200819, Toronto

National Cancer Center Hospital East /ID# 216870, Kashiwa-shi

National Cancer Center Hospital /ID# 217758, Chuo-ku

Seoul National University Hospital /ID# 166291, Seoul

Yonsei University Health System Severance Hospital /ID# 166292, Seoul